DLK1 and neoplasm: The MS17-57 target(s) might have different features than those of GI tumor-associated Ags [22,23] or other proteins (e.g., CEA [24], CA15-3 [25], PG-1 (pepsinogen-1), PG-2 [26], and Helicobacter pylori lysates [27]).